Cargando…

Oral Anticoagulant Treatment and the Risk of Dementia in Patients With Atrial Fibrillation: A Population‐Based Cohort Study

BACKGROUND: We compared the dementia incidence rate between users and nonusers of oral anticoagulants (OACs) in a large cohort of primary care patients with atrial fibrillation. METHODS AND RESULTS: We performed a retrospective study using an Australia‐wide primary care data set, MedicineInsight. Pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bezabhe, Woldesellassie M., Bereznicki, Luke R., Radford, Jan, Wimmer, Barbara C., Salahudeen, Mohammed S., Garrahy, Edward, Bindoff, Ivan, Peterson, Gregory M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075457/ https://www.ncbi.nlm.nih.gov/pubmed/35301852 http://dx.doi.org/10.1161/JAHA.121.023098

Ejemplares similares

Five-Year Trends in Potential Drug Interactions with Direct-Acting Oral Anticoagulants in Patients with Atrial Fibrillation: An Australian-Wide Study
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2020)

Incidence of Osteoporosis in Primary Care Patients with Atrial Fibrillation Receiving Different Oral Anticoagulants
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2022)

Ten-Year Trends in the Use of Oral Anticoagulants in Australian General Practice Patients With Atrial Fibrillation
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2021)

Ten-Year Trends in Psychotropic Prescribing and Polypharmacy in Australian General Practice Patients with and without Dementia
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2023)

Oral Anticoagulant Discontinuation and Its Predictors in Patients with Atrial Fibrillation
por: Kefale, Adane Teshome, et al.
Publicado: (2022)

Improving Knowledge and Early Detection of Atrial Fibrillation through a Community-Based Opportunistic Screening Program: What’s Your Beat?
por: Jatau, Abubakar Ibrahim, et al.
Publicado: (2022)

Oral Anticoagulant Use in Patients with Atrial Fibrillation at Low Risk of Stroke and Associated Bleeding Complications
por: Kefale, Adane Teshome, et al.
Publicado: (2023)

Development and Validation of an Atrial Fibrillation Knowledge Assessment Tool (AFKAT)
por: Jatau Abubakar, Ibrahim, et al.
Publicado: (2020)

Applying the Capability, Opportunity, and Motivation Behaviour Model (COM-B) to Guide the Development of Interventions to Improve Early Detection of Atrial Fibrillation
por: Jatau, Abubakar Ibrahim, et al.
Publicado: (2019)

Medication Prescribing Quality in Australian Primary Care Patients with Chronic Kidney Disease
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2020)

Adherence to Antiretroviral Therapy and Virologic Failure: A Meta-Analysis
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2016)

Adherence to antiretroviral drug therapy in adult patients who are HIV-positive in Northwest Ethiopia: a study protocol
por: Bezabhe, Woldesellassie M, et al.
Publicado: (2013)

Barriers and Facilitators of Adherence to Antiretroviral Drug Therapy and Retention in Care among Adult HIV-Positive Patients: A Qualitative Study from Ethiopia
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2014)

Ten-year trends in adverse drug reaction–related hospitalizations among people with dementia
por: Zaidi, Anum Saqib, et al.
Publicado: (2022)

Comments: Absolute cardiovascular risk assessment for guiding antihypertensive prescribing in Australian primary care patients with hypertension
por: Bezabhe, Woldesellassie M., et al.
Publicado: (2022)

Quality use of medicines in patients with chronic kidney disease
por: Castelino, Ronald L., et al.
Publicado: (2020)

Computer-Based Simulators in Pharmacy Practice Education: A Systematic Narrative Review
por: Gharib, Ahmed M., et al.
Publicado: (2023)

Potential Barriers to the Implementation of Computer-Based Simulation in Pharmacy Education: A Systematic Review
por: Gharib, Ahmed M., et al.
Publicado: (2023)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Comparative Effectiveness and Safety of Oral Anticoagulants by Dementia Status in Older Patients With Atrial Fibrillation
por: Lin, Kueiyu Joshua, et al.
Publicado: (2023)

Association of Oral Anticoagulant Type With Risk of Dementia Among Patients With Nonvalvular Atrial Fibrillation
por: Chen, Nemin, et al.
Publicado: (2018)

Anticoagulant prescribing for atrial fibrillation and risk of incident dementia
por: Cadogan, Sharon Louise, et al.
Publicado: (2021)

Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation
por: Friberg, Leif, et al.
Publicado: (2019)

Patients’ Perspectives on Commencing Oral Anticoagulants in Atrial Fibrillation: An Exploratory Qualitative Descriptive Study
por: Gebreyohannes, Eyob Alemayehu, et al.
Publicado: (2023)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

The new oral anticoagulants in atrial fibrillation: an update
por: Verheugt, F. W. A.
Publicado: (2013)

Satisfaction with oral anticoagulants in patients with atrial fibrillation
por: Suárez Fernández, Carmen, et al.
Publicado: (2018)

Comparison of renin–angiotensin–aldosterone system inhibitors with other antihypertensives in association with coronavirus disease-19 clinical outcomes
por: Bezabih, Yihienew M., et al.
Publicado: (2021)

Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation
por: da Silva, Rose M.F.L.
Publicado: (2014)

Atrial Fibrillation and Risk of Dementia: Epidemiology, Mechanisms, and Effect of Anticoagulation
por: Silva, Rose Mary Ferreira Lisboa Da, et al.
Publicado: (2019)

Is there a connection among atrial fibrillation, anticoagulant treatment, and dementia?
por: Ferri, Claudio, et al.
Publicado: (2020)

Development and Validation of an Oral Anticoagulation Knowledge Tool (AKT)
por: Obamiro, Kehinde O., et al.
Publicado: (2016)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)

Characterization of patients with atrial fibrillation not treated with oral anticoagulants
por: Johansson, Cecilia, et al.
Publicado: (2014)

Oral Anticoagulants for Atrial Fibrillation Patients with Active Cancer
por: Kim, Do Young, et al.
Publicado: (2018)

Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation
por: Giustozzi, Michela, et al.
Publicado: (2019)

Novel Oral Anticoagulants in Atrial Fibrillation: Update on Apixaban
por: Mezue, Kenechukwu, et al.
Publicado: (2017)

Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation
por: Reiffel, James A.
Publicado: (2018)

The temporal context of oral anticoagulation outcome in atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2022)

Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation
por: Galea, Roberto, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hnfgab9bfj6s69q5mrgphfhg72